Bio-Rad Laboratories, Inc. BIO
Set alert
375.65 USD +9.49 +2.59%
As of Nov 3, 1:24 PM ET
369.86 Day range 376.81
236.73 52-week range 396.23
- YTD
- +23.98%
- 1 year
- +20.62%
- Open
- 369.45
- Prev close
- 366.16
- Mkt cap
- 10.05B
- Vol
- 72.37K
- Avg vol
- 254.03K
- EPS
- 7.89
- P/E
- 47.63
- Div yield
- 0.00%
More statistics
- Low
- 369.86
- High
- 376.81
- Forward P/E
- 37.57
- Beta
- 1.06
- Short ratio
- 4.17
- Inst. own
- 91.74%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 374.80
- 200-d avg
- 313.41
- 1y target
- 335.00
5Y chart
Events in this range
- Jul 31, 2025Earnings: 2.61; estimate 1.93; surprise 35.23%
- Oct 29, 2025Earnings: 2.26; estimate 2.3; surprise -1.74%
- Feb 12, 2026Earnings: 2.51; estimate 2.57; surprise -2.33%
- Apr 7, 2026Downgrade: Citigroup · Buy → Neutral
- Apr 30, 2026Earnings: 1.89; estimate 1.97; surprise -4.06%
- May 1, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Aug 4, 2026Earnings: 2.62; estimate 1.75; surprise 49.71%
- Aug 5, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Aug 5, 2026Rating: RBC Capital · Outperform → Outperform
- Aug 5, 2026Rating: Citigroup · Neutral → Neutral
- Aug 7, 2026Rating: RBC Capital · Outperform → Outperform
- Nov 4, 2026Earnings: —; estimate 2.23; surprise —%
Signals (83)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Jun 22, 2026 | 4 months ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| MACD: Buy Signal | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | Apr 27, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 10 months ago |
Newest 20 of 83.
Analyst view
Consensus: hold
Hold
Price target (mean) 335.00 -10.8% downside
Now 375.65
- Target (low)
- 280.00
- Target (mean)
- 335.00
- Target (high)
- 390.00
Ratings (0m) 3 1 buy · 1 hold · 1 sell
- Strong buy1
- Buy0
- Hold1
- Sell0
- Strong sell1
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.23 | 2.16 – 2.29 | 2.26 | -1.6% | 649.95M | -0.5% | 2 |
| Next quarter | 3.02 | 2.74 – 3.30 | 2.51 | +20.3% | 695.40M | +0.3% | 2 |
| Current year | 9.45 | 8.85 – 10.10 | 9.92 | -4.7% | 2.57B | -0.5% | 3 |
| Next year | 9.75 | 8.75 – 10.90 | 9.45 | +3.1% | 2.62B | +2.1% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 7, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Feb 16, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2025 | Citigroup | Maintained | Buy | Buy |
| Oct 30, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 1, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 1, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jun 9, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 2, 2025 | UBS | Maintained | Buy | Buy |
| May 2, 2025 | Citigroup | Maintained | Buy | Buy |
| May 2, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 17, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 12, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 14, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| Dec 9, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 31, 2024 | Citigroup | Maintained | Buy | Buy |
| Oct 31, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 1, 2024 | Citigroup | Upgrade | Neutral | Buy |
| Aug 27, 2024 | Wells Fargo | Initiated | — | Equal-Weight |
| Aug 16, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 2, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 2, 2024 | Citigroup | Maintained | Neutral | Neutral |
| May 8, 2024 | UBS | Maintained | Buy | Buy |
| Apr 3, 2024 | Citigroup | Downgrade | Buy | Neutral |
| Feb 16, 2024 | UBS | Maintained | Buy | Buy |
| Feb 16, 2024 | RBC Capital | Maintained | Outperform | Outperform |